BDBM238277 2-[5-hydroxy-5-(2- phenylethyl)- octahydrocyclopenta[c] pyrrol-2-yl]-1-(4- phenylphenyl)ethan-1- one::US10052306, 269

SMILES OC1(CCc2ccccc2)C[C@@H]2CN(CC(=O)c3ccc(cc3)-c3ccccc3)C[C@@H]2C1

InChI Key InChIKey=CMSXFBTWLNFBLG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238277   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM238277(2-[5-hydroxy-5-(2- phenylethyl)- octahydrocyclopen...)
Affinity DataIC50: 1.00E+4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent